A Randomized, Controlled Trial of Gabapentin Enacarbil in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy.

Background Gabapentin enacarbil ( GEn), a transported prodrug of gabapentin, provides sustained, dose-proportional gabapentin exposure. The purpose of this study was to investigate the dose response of GEn to select the optimal dose(s) for clinical use in subsequent diabetic peripheral neuropathy (...

Descripción completa

Detalles Bibliográficos

Publicado en:	Pain Practice Vol. 13; no. 6; pp. 485 - 497
Autores principales:	Rauck, Richard, Makumi, Clare W., Schwartz, Sherwyn, Graff, Ole, Meno-Tetang, Guy, Bell, Christopher F., Kavanagh, Sarah T., McClung, Carrie L.
Formato:	research tables/charts randomized controlled trial Journal Article
Publicado:	Wiley-Blackwell Jul2013
Acceso en línea:	Ver este registro en EBSCOhost